237-272-7 | Sigma-Aldrich

Caspase 8 human (C1099)

Biochem. Sci., 22(8), 299-306 (1997). 7. Scaffidi, C., et al., J. Biol. Chem., 272(43), 26953- 26958 (1997). 8. Hu, S., et al., J. Biol. Chem., 272(28), 17255-17257 (1997). 9. Martin, D.A

MMP Activation Chart

Collagenase 72 aa=71.0 active-MMP-7 37oC, 8h C ? n.d. 0.6x Stetler-Stevenson et al., jbc 1989, 264, 1353; Nagase et al., Matrix Suppl. 1992 1:237 Crabbe FEBS

RABBIT ANTI-CXCR4 (EXTRACELLULAR LOOP)

Nature. 382:829-833. 7. Oberlin, E et al. (1996) Nature. 382:833-835. 8. Lapham, CK et al. (1996) Science. 274:602-605. 9. Leotscher, M et al. (1994) J Biol Chem. 269:232-237. 10. Brelot, A et al.

Product Information Sheet - C1224

pentapeptide of general structure QACXG (where X is R, Q or G). The amino acids Cys 285 and His 237 involved in catalysis, and those involved in forming the P1 carboxylate binding pocket (Arg

Data Sheet - C8352

transmembrane domain receptor, LESTR, that is highly expressed in leukocytes. J. Biol. Chem., 269, 232-237 (1994). 3. Wells, T.N., et al., Definition, function and pathophysiological significance of chemokine

Data Sheet - C8227

transmembrane domain receptor, LESTR, that is highly expressed in leukocytes. J. Biol. Chem., 269, 232-237 (1994). 3. Wells, T.N., et al., Definition, function and pathophysiological significance of chemokine

CAPASE 6 HUMAN RECOMBINANT C-terminal histidine tagged protein Expressed in E. coli

pentapeptide of general structure QACXG (where X is R, Q or G). The amino acids Cys-285 and His-237 involved in catalysis, and those involved in forming the P1 carboxylate binding pocket (Arg-179

Data Sheet - A7310

Fushimi, K. et al., J. Biol. Chem., 272, 14800 (1997). 6. Preston, B.M., et al., Science 256, 385 (1992). 7. Ishibashi, K., et al., Biochem. Biophys. Res. Commun. 237, 714 (1997). 8. Park, J.H. and

Data Sheet - A0303

Ishibashi, K., et al., Am. J. Physiol., 272, F235 (1997). 6. Preston, B.M., et al., Science 256, 385 (1992). 7. Ishibashi, K., et al., Biochem. Biophys. Res. Commun. 237, 714 (1997). 8. Park, J.H. and Saier

XP725 Antibody Number-Lot Number 071M4826

278 279 280 3.5 209 210 211 212 233 234 235 236 257 258 259 260 281 282 283 284 3.6 213 214 215 216 237 238 239 240 261 262 263 264 285 286 287 288 4.1 289 290 291 292 313

LABORATORY NOTEBOOK ISSUANCE PAGE

Neodymium Nd 60 144.242(3) Neon Ne 10 20.1797(6) Neptunium Np 93 [237] Nickel Ni 28 58.6934(4) Niobium Nb 41 92.906 38(2) Nitrogen N 7 [14.006 43; 14.007 28] Nobelium No 102 [259] Osmium Os 76 190.23(3

Lab Notebook Guidelines

Neodymium Nd 60 144.242(3) Neon Ne 10 20.1797(6) Neptunium Np 93 [237] Nickel Ni 28 58.6934(4) Niobium Nb 41 92.906 38(2) Nitrogen N 7 [14.006 43; 14.007 28] Nobelium No 102 [259] Osmium Os 76 190.23(3

LABORATORY NOTEBOOK ISSUANCE PAGE

Neodymium Nd 60 144.242(3) Neon Ne 10 20.1797(6) Neptunium Np 93 [237] Nickel Ni 28 58.6934(4) Niobium Nb 41 92.906 38(2) Nitrogen N 7 [14.006 43; 14.007 28] Nobelium No 102 [259] Osmium Os 76 190.23(3

LABORATORY NOTEBOOK ISSUANCE PAGE

Neodymium Nd 60 144.242(3) Neon Ne 10 20.1797(6) Neptunium Np 93 [237] Nickel Ni 28 58.6934(4) Niobium Nb 41 92.906 38(2) Nitrogen N 7 [14.006 43; 14.007 28] Nobelium No 102 [259] Osmium Os 76 190.23(3

FlowCellect™ Chemokine Receptor CCR2b Surface Expression Identification kit

Evidence for the role of the carboxyl-terminal tail in receptor trafficking. J. Biol. Chem. 272: 1038-45. 7. Schertler GFX (1992). Overproduction of membrane proteins. Curr Opin Struct Biol. 2: 534-

Research Article: MCP-1, KC-like and IL-8 as critical mediators of

Uncomplicated day 7 (n = 13) Min-Max 139–272 117–2009 12–276 39–183 1391–6294 1–1 29–1109 2–762 156–282 Median 154 440 28 68 2852 1 184 145 191 SD 44 474 87 48 1362 0 309 231 42

XP725 Antibody List Lot 129K4831

n/d n/d 272 FBI-1/PAKEMON F9429 51341 ZBTB7A P NP_056982.1 y n/d n/d 155 Cdh1 C7855 51343 FZR1 M NP_001129669.1 y n/d n/d 333 HDAC-7 H2537 51564 HDAC7 P NP_001091886.1 y y y 334 HDAC-7 H6663 51564

XP725 Antibody List Lot 129K4830

n/d n/d 272 FBI-1/PAKEMON F9429 51341 ZBTB7A P NP_056982.1 y n/d n/d 155 Cdh1 C7855 51343 FZR1 M NP_001129669.1 y n/d n/d 333 HDAC-7 H2537 51564 HDAC7 P NP_001091886.1 y y y 334 HDAC-7 H6663 51564

XP725 Antibody List Lot 089K4791

n/d n/d 272 FBI-1/PAKEMON F9429 51341 ZBTB7A P NP_056982.1 y n/d n/d 155 Cdh1 C7855 51343 FZR1 M NP_001129669.1 y n/d n/d 333 HDAC-7 H2537 51564 HDAC7 P NP_001091886.1 y y y 334 HDAC-7 H6663 51564

XP725 Worksheet for Lot Number 071M4826

231 2 1 5 7 Caspase 4 C3392 232 2 1 5 8 Caspase 4 C3392 233 2 1 6 1 Caspase 5 C6979 234 2 1 6 2 Caspase 5 C6979 235 2 1 6 3 Caspase 6 C7599 236 2 1 6 4

List of Antibodies

DR4 D3813 P y n/d n/d 234 DR5 D3938 P y n/d n/d 235 DR6 D1564 P y n/d n/d 236 DRAK1 D1314 P y y y 237 Dystrophin D8168 M y y y 238 Dystrophin D8043 M y y y 239 E2F1 E9026 P y

3D BIOPRINTING: Printing a Brighter Future

Physiol. Heart Circ. 1997, 272 (6), H2716–H2725. (6) Dhinakaran, V.; Kumar, K.; Ram, P.; Ravichandran, M.; Vinayagamoorthy, M. Mater. Today: Proc. 2020, 27, 752–756. (7) Melchels, F.; Feijen, J.; Grijpma

3D BIOPRINTING: Printing a Brighter Future

Physiol. Heart Circ. 1997, 272 (6), H2716–H2725. (6) Dhinakaran, V.; Kumar, K.; Ram, P.; Ravichandran, M.; Vinayagamoorthy, M. Mater. Today: Proc. 2020, 27, 752–756. (7) Melchels, F.; Feijen, J.; Grijpma

XP725 Antibody List

235 DR6 D1564 27242 TNFRSF21 NP_055267.1 P y n/d n/d 236 DRAK1 D1314 9263 STK17A NP_004751.2 P y y y 237 Dystrophin D8168 24907, 1756, 13405 DMD,Dmd NP_036830.2,NP_004014.1,NP_031894.1 M y y y 238 Dystrophin

XP725 Antibody List 013M4793

235 DR6 D1564 27242 TNFRSF21 NP_055267.1 P y n/d n/d 236 DRAK1 D1314 9263 STK17A NP_004751.2 P y y y 237 Dystrophin D8168 24907, 1756, 13405 DMD,Dmd NP_036830.2,NP_004014.1,NP_031894.1 M y y y 238 Dystrophin

Halal Certificate

Butenal W364620 B43996 HC-23SI9F48 236. 3-METHYL-2-CYCLOHEXENONE 98% W336009 A56162 HC-23SIX118 237. 3-METHYLBUTYL 2-METHYLBUTANOATE 98% W350508 B83812 HC-23SI5231 238. 3-METHYLBUTYL 2-METHYLBUTANOATE

Halal Certificate

Butenal W364620 B43996 HC-22SI9Z69 236. 3-METHYL-2-CYCLOHEXENONE 98% W336009 A56162 HC-22SIWV39 237. 3-METHYLBUTYL 2-METHYLBUTANOATE 98% W350508 B83812 HC-22SI7552 238. 3-METHYLBUTYL 2-METHYLBUTANOATE